Altogether, these data point to different tumor-associated factors (i.e., IL-10, IL-6, PGE2) exerting their suppressive effects at various stages of myeloid DC development through converging and communicating signaling elements encompassing the JAK2/STAT3 and p38-MAPK pathways (Figure 2). This evidence concerns the gene JAK2 and neoplasm.